Scisparc engages investment bank to identify potential strategic transaction opportunities

Tel aviv, israel, sept. 12, 2023 (globe newswire) -- scisparc ltd. (nasdaq: sprc) ("company" or "scisparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it has engaged rosario capital ltd. ("rosario capital"), one of israel' leading investment banks, to identify potential opportunities for a strategic transaction.
SPRC Ratings Summary
SPRC Quant Ranking